Peptide dose, affinity, and time of differentiation can contribute to the Th1/Th2 cytokine balance.

Opposing viewpoints exist regarding how Ag dose and affinity modulate Th1/Th2 differentiation, with data suggesting that both high and low level stimulation favors Th2 responses. With transgenic T cells bearing a single TCR, we present novel data, using peptides differing in affinity for the TCR, that show that the time period of differentiation can determine whether Th1 or Th2 responses predominate as the level of initial stimulation is altered. Over the short term, IFN-gamma-producing cells were induced by lower levels of stimulation than IL-4-producing cells, although optimal induction of both was seen with the same high level of stimulation. Over the long term, however, high doses of high affinity peptides led selectively to IFN-gamma-secreting cells, whereas IL-4- and IL-5-secreting cells predominated with lower levels of initial signaling, brought about by moderate doses of high affinity peptides. In contrast, too low a level of stimulation at the naive T cell stage, with low affinity peptides at any concentration, promoted only IL-2-secreting effectors or was not sufficient for long term T cell survival. These results demonstrate that the level of signaling achieved through the TCR is intimately associated with the induction of distinct cytokine-secreting T cells. We show that dose, affinity, time over which differentiation occurs, and initial production of IL-4 and IFN-gamma all can contribute to which T cell subset will predominate. Furthermore, these data reconcile the two opposing views on the effects of dose and affinity and provide a unifying model of Th1/Th2 differentiation based on strength of signaling and length of response.

[1]  W. Paul,et al.  Acquisition of lymphokine-producing phenotype by CD4+ T cells. , 1994, Annual review of immunology.

[2]  P. Linsley,et al.  B7-CD28/CTLA-4 costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens. , 1997, Journal of immunology.

[3]  Paul C. Rogers,et al.  From Naive to Memory T Cells , 1996, Immunological reviews.

[4]  D. Loh,et al.  Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. , 1994, Immunity.

[5]  H. Grey,et al.  Modulation of naive CD4 T cell activation with altered peptide ligands: the nature of the peptide and presentation in the context of costimulation are critical for a sustained response. , 1998, Journal of immunology.

[6]  D. Umetsu,et al.  Cross-linking of the CD40 ligand on human CD4+ T lymphocytes generates a costimulatory signal that up-regulates IL-4 synthesis. , 1996, Journal of immunology.

[7]  P. Kaye,et al.  B7-2 blockade enhances T cell responses to Leishmania donovani. , 1997, Journal of immunology.

[8]  A. Sette,et al.  Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon gamma by T cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Y. Chien,et al.  A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. , 1996, Immunity.

[10]  H. Reiser,et al.  Costimulation of IL-4 production by murine B7-1 and B7-2 molecules. , 1996, Journal of immunology.

[11]  A Radbruch,et al.  Induction of interleukin 4 (IL-4) expression in T helper (Th) cells is not dependent on IL-4 from non-Th cells , 1994, The Journal of experimental medicine.

[12]  V. Kuchroo,et al.  Autopathogenic T Helper Cell Type 1 (Th1) and Protective Th2 Clones Differ in Their Recognition of the Autoantigenic Peptide of Myelin Proteolipid Protein , 1997, The Journal of experimental medicine.

[13]  M. Croft,et al.  Response of naive antigen-specific CD4+ T cells in vitro: characteristics and antigen-presenting cell requirements , 1992, The Journal of experimental medicine.

[14]  M. Croft,et al.  CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response. , 1997, Journal of immunology.

[15]  P. Rogers,et al.  High antigen density and IL-2 are required for generation of CD4 effectors secreting Th1 rather than Th0 cytokines. , 1998, Journal of immunology.

[16]  S. Matsushita,et al.  Altered TCR ligands affect antigen-presenting cell responses: up-regulation of IL-12 by an analogue peptide. , 1996, Journal of immunology.

[17]  S. Constant,et al.  Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. , 1997, Annual review of immunology.

[18]  C. June,et al.  CD28‐deficient mice generate an impaired Th2 response to Schistosoma mansoni infection , 1996, European journal of immunology.

[19]  G. Delespesse,et al.  Human naive CD4 T cells produce interleukin‐4 at priming and acquire a Th2 phenotype upon repetitive stimulations in neutral conditions , 1995, European journal of immunology.

[20]  T. Schountz,et al.  MHC genotype controls the capacity of ligand density to switch T helper (Th)-1/Th-2 priming in vivo. , 1996, Journal of immunology.

[21]  D. Green,et al.  Unequal Death in T Helper Cell (Th)1 and Th2 Effectors: Th1, but not Th2, Effectors Undergo Rapid Fas/FasL-mediated Apoptosis , 1997, The Journal of experimental medicine.

[22]  A. Berns,et al.  Peripheral T Cell Survival Requires Continual Ligation of the T Cell Receptor to Major Histocompatibility Complex–Encoded Molecules , 1997, The Journal of experimental medicine.

[23]  H. Burstein,et al.  Aqueous antigens induce in vivo tolerance selectively in IL-2- and IFN-gamma-producing (Th1) cells. , 1992, Journal of immunology.

[24]  C. June,et al.  CD28 activation promotes Th2 subset differentiation by human CD4+ cells , 1995, European journal of immunology.

[25]  R. Karr,et al.  Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. , 1995, Journal of immunology.

[26]  S. Constant,et al.  Induction of IL-4-producing CD4+ T cells by antigenic peptides altered for TCR binding. , 1997, Journal of immunology.

[27]  A. Sher,et al.  Comparison of Th1- and Th2-associated immune reactivities stimulated by single versus multiple vaccination of mice with irradiated Schistosoma mansoni cercariae. , 1991, Journal of immunology.

[28]  J. Kazura,et al.  B7-2 requirement for helminth-induced granuloma formation and CD4 type 2 T helper cell cytokine expression. , 1997, Journal of immunology.

[29]  C. Turck,et al.  Impaired Th2 subset development in the absence of CD4. , 1997, Immunity.

[30]  M. Davis,et al.  Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Croft,et al.  Generation, persistence, and modulation of Th0 effector cells: role of autocrine IL-4 and IFN-gamma. , 1998, Journal of immunology.

[32]  J. Saurat,et al.  Lectin-mediated induction of IL-4-producing CD4+ T cells. , 1991, Journal of immunology.

[33]  M. Croft,et al.  Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines. , 1995, Journal of immunology.

[34]  T. Brocker Survival of Mature CD4 T Lymphocytes Is Dependent on Major Histocompatibility Complex Class II–expressing Dendritic Cells , 1997, The Journal of experimental medicine.

[35]  S. Constant,et al.  Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation. , 1997, Journal of immunology.

[36]  L. Adorini,et al.  Soluble protein but not peptide administration diverts the immune response of a clonal CD4+ T cell population to the T helper 2 cell pathway. , 1996, Journal of immunology.

[37]  D. Umetsu,et al.  Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type , 1995, The Journal of experimental medicine.

[38]  L. Adorini,et al.  Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)- microglobulin-deficient BALB/c mice , 1996, The Journal of experimental medicine.

[39]  S. Szabo,et al.  Genes that regulate interleukin-4 expression in T cells. , 1997, Current opinion in immunology.

[40]  J. Gribben,et al.  B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. , 1995, Immunity.

[41]  K. Murphy,et al.  The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model , 1995, The Journal of experimental medicine.

[42]  H. Bielefeldt-Ohmann,et al.  Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. , 1992, Science.

[43]  F. Finkelman,et al.  CD28 dependence of T cell differentiation to IL-4 production varies with the particular type 2 immune response. , 1997, Journal of immunology.

[44]  J. Saurat,et al.  Central role for TCR/CD3 ligation in the differentiation of CD4+ T cells toward A Th1 or Th2 functional phenotype. , 1992, Journal of immunology.

[45]  J. Sidney,et al.  Effect of pH on MHC class II-peptide interactions. , 1992, Journal of immunology.

[46]  M. Croft,et al.  Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. , 1995, Journal of immunology.

[47]  A. Sette,et al.  Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo , 1995, The Journal of experimental medicine.

[48]  P. Linsley,et al.  Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. , 1994, Journal of immunology.

[49]  K. Else,et al.  Low‐level infection with Trichuris muris significantly affects the polarization of the CD4 response , 1994, European journal of immunology.

[50]  V. Kuchroo,et al.  An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. , 1995, Immunity.

[51]  Chyung-Ru Wang,et al.  Helper T cell differentiation is controlled by the cell cycle. , 1998, Immunity.

[52]  F. Ramsdell,et al.  Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. , 1994, International immunology.

[53]  P. Lehmann,et al.  Induction of TH1 and TH2 Immunity in Neonatal Mice , 1996, Science.

[54]  E. Sercarz,et al.  Neonatal peptide exposure can prime T cells and, upon subsequent immunization, induce their immune deviation: implications for antibody vs. T cell-mediated autoimmunity , 1996, The Journal of experimental medicine.

[55]  J. Bluestone,et al.  CD28 costimulation promotes the production of Th2 cytokines. , 1997, Journal of immunology.

[56]  N. Killeen,et al.  A Role for CD4 in Peripheral T Cell Differentiation , 1997, The Journal of experimental medicine.

[57]  M. Croft,et al.  A direct role for IFN-gamma in regulation of Th1 cell development. , 1996, Journal of immunology.

[58]  V. Kuchroo,et al.  B7-2 (CD86) is essential for the development of IL-4-producing T cells. , 1996, International immunology.

[59]  A. Woodard,et al.  Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells , 1995, The Journal of experimental medicine.

[60]  D. Abramowicz,et al.  The injection of deaggregated gamma globulins in adult mice induces antigen-specific unresponsiveness of T helper type 1 but not type 2 lymphocytes , 1992, The Journal of experimental medicine.